Scientific Library
- Acute Coronary Syndrom
- ASCVD Prevention
- Bifurcation Stenting
- Cardio-Oncology
- Congestive Heart Failure
- DAPT Duration
- Drug Coated Balloon
- Fractional Flow Reserve
- IVUS Guidance
- Optical Coherence Tomography
- Pulmonary Hypertension
- Rotational Atherectomy
- Shear Stress
- Stenting Left Main
- Transcatheter Aortic Valve Replacement
- Percutaneous LAA Occlusion
- Mitral/Tricuspid Valvular Disease
- Other Relevant Articles
-
Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysisM Gaudino, I Hameed, ME Farkouh et al. -
LOX-1 in Atherosclerosis and Myocardial Ischemia: Biology, Genetics, and ModulationPothineni NVK, Karathanasis SK, Mehta JL et al.
-
A Randomized Trial to Assess Regional Left Ventricular Function After Stent Implantation in Chronic Total Occlusion The REVASC TrialK Mashayekhi, TG Nührenberg, A Toma et al.
-
Blood CSF1 and CXCL12 as Causal Mediators of Coronary Artery DiseaseJ Sjaarda, H Gerstein, M Chong et al. -
Management of No-Reflow Phenomenon in the Catheterization LaboratoryRezkalla SH, Stankowski RV, Hanna J et al.
-
ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed TomographyPatel MR, Dehmer GJ, American College of Cardiology Foundation Appropriateness Criteria Task Force et al.
-
Management of two major complications in the cardiac catheterisation laboratory: the no-reflow phenomenon and coronary perforationsMuller O, Windecker S, Cuisset T et al.
-
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart AssociationCB Newman and and on behalf of the American Heart Association Clinical Lipidology, Lipoprotein, Metabolism and Thrombosis Committee, a Joint Committee of the Council on Atherosclerosis, Thrombosis and Vascular Biology and Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
